The Institute of Bioorganic Chemistry, Polish Academy of Sciences
National Center for Research and Development, Poland
Age
18–any
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Men or women ≥18 years of age
Patients with informed consent to participate in the study.
Men or women ≥18 years of age
Patients with melanoma
Patients with informed consent to participate in the study.
Patients receiving routine treatment (immunotherapy using anti-PD1 / anti-PDL1 and / or anti CTLA4 antibodies), financed by the Polish National Health Fund (NFZ).
The applied immunotherapy should be the first or second line of treatment.
You may not be if
Patients or Healthy Volunteers who are unable to understand, read and / or sign the informed consent
Patients or Healthy Volunteers who can not collect stools
Patients with a fecal transplant
The applied immunotherapy is not the first or second line of treatment.
